Vinblastine ( DrugBank: Vinblastine )

2 diseases

ID	Disease name (Link within this page)	Number of trials
34	Neurofibromatosis	3
65	Primary immunodeficiency	1

34. Neurofibromatosis

Clinical trials : 133 / Drugs : 186 - (DrugBank : 67) / Drug target genes : 79 - Drug target pathways : 190

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2012-003005-10-DK (EUCTR)	06/06/2013	08/05/2013	LOW-GRADE GLIOMA	PHASE I-II STUDY OF VINBLASTINEIN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADU ...	Children, adolescents and young adults with refractory or recurrent low-grade gliomas, and children, ...	Product Name: Nilotinib Product Code: AMN107 Other descriptive name: NILOTINIB HYDROCHLORIDE MONOHYDRA ...	Gustave Roussy	NULL	Not Recruiting			Female: yes Male: yes	160	Phase 2	France;Spain;Denmark;Netherlands;Switzerland
2	NCT00352495 (ClinicalTrials.gov)	June 2006	13/7/2006	Vinblastineand Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Gl ...	A Phase I Study of Vinblastinein Combination With Carboplatin for Children With Newly Diagnosed and ...	Brain and Central Nervous System Tumors;Neurofibromatosis Type 1	Drug: carboplatin;Drug: vinblastine sulfate	Children's Oncology Group	National Cancer Institute (NCI)	Completed	N/A	21 Years	Both	26	Phase 1	United States;Canada
3	NCT00030264 (ClinicalTrials.gov)	February 2001	14/2/2002	Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neuro ...	Vinblastine/Methotrexate For Severe Progressive Plexiform Neurofibromas: A Phase II Study	Neurofibromatosis Type 1;Precancerous Condition	Drug: Methotrexate;Drug: Vinblastine	Children's Hospital of Philadelphia	NULL	Completed	N/A	25 Years	All	23	Phase 2	United States

First Previous1Next Last

65. Primary immunodeficiency

Clinical trials : 500 / Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00187057 (ClinicalTrials.gov)	September 2002	12/9/2005	Study for Treatment of Cancer in Children With Ataxia-telangiectasia	Pilot Study I for Treatment of Cancer in Children With Ataxia-Telangiectasia	Ataxia-Telangiectasia	Drug: vinblastine, vincristine, prednisone, daunorubicin;Drug: doxorubicin, methotrexate, cyclophosp ...	St. Jude Children's Research Hospital	Children's Hospital of Philadelphia;National Cancer Institute (NCI)	Completed	N/A	10 Years	Both	6	N/A	United States

First Previous1Next Last